204 related articles for article (PubMed ID: 23824493)
1. Sphingosine-1-Phosphate as a Regulator of Hypoxia-Induced Factor-1α in Thyroid Follicular Carcinoma Cells.
Kalhori V; Kemppainen K; Asghar MY; Bergelin N; Jaakkola P; Törnquist K
PLoS One; 2013; 8(6):e66189. PubMed ID: 23824493
[TBL] [Abstract][Full Text] [Related]
2. Macrophage Motility in Wound Healing Is Regulated by HIF-1α via S1P Signaling.
Hutami IR; Izawa T; Khurel-Ochir T; Sakamaki T; Iwasa A; Tanaka E
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445695
[TBL] [Abstract][Full Text] [Related]
3. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α controls palatal wound healing by regulating macrophage motility via S1P/S1P
Hutami IR; Izawa T; Khurel-Ochir T; Sakamaki T; Iwasa A; Tomita S; Tanaka E
Oral Dis; 2022 May; 28(4):1157-1169. PubMed ID: 33759275
[TBL] [Abstract][Full Text] [Related]
5. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy.
Ader I; Malavaud B; Cuvillier O
Cancer Res; 2009 May; 69(9):3723-6. PubMed ID: 19383898
[TBL] [Abstract][Full Text] [Related]
6. Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate.
Hait NC; Maiti A; Xu P; Qi Q; Kawaguchi T; Okano M; Takabe K; Yan L; Luo C
FASEB J; 2020 Mar; 34(3):4293-4310. PubMed ID: 32017264
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity.
Liu F; Verin AD; Wang P; Day R; Wersto RP; Chrest FJ; English DK; Garcia JG
Am J Respir Cell Mol Biol; 2001 Jun; 24(6):711-9. PubMed ID: 11415936
[TBL] [Abstract][Full Text] [Related]
8.
Canales J; Valenzuela M; Bravo J; Cerda-Opazo P; Jorquera C; Toledo H; Bravo D; Quest AF
Front Cell Infect Microbiol; 2017; 7():92. PubMed ID: 28401064
[No Abstract] [Full Text] [Related]
9. Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells.
Michaud MD; Robitaille GA; Gratton JP; Richard DE
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):902-8. PubMed ID: 19423865
[TBL] [Abstract][Full Text] [Related]
10. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.
Schnitzer SE; Weigert A; Zhou J; Brüne B
Mol Cancer Res; 2009 Mar; 7(3):393-401. PubMed ID: 19240180
[TBL] [Abstract][Full Text] [Related]
12. Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific.
Baudhuin LM; Cristina KL; Lu J; Xu Y
Mol Pharmacol; 2002 Sep; 62(3):660-71. PubMed ID: 12181443
[TBL] [Abstract][Full Text] [Related]
13. Berberine Preconditioning Protects Neurons Against Ischemia via Sphingosine-1-Phosphate and Hypoxia-Inducible Factor-1[Formula: see text].
Zhang Q; Bian H; Guo L; Zhu H
Am J Chin Med; 2016; 44(5):927-41. PubMed ID: 27430910
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between PI3K and Ras pathways via protein phosphatase 2A in human ovarian clear cell carcinoma.
Takai M; Nakagawa T; Tanabe A; Terai Y; Ohmichi M; Asahi M
Cancer Biol Ther; 2015; 16(2):325-35. PubMed ID: 25756515
[TBL] [Abstract][Full Text] [Related]
15. Rapid non-genomic signalling by 17β-oestradiol through c-Src involves mTOR-dependent expression of HIF-1α in breast cancer cells.
Sudhagar S; Sathya S; Lakshmi BS
Br J Cancer; 2011 Sep; 105(7):953-60. PubMed ID: 21897387
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
17. Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1α expression by blocking protein translation and increases cell death under hypoxia.
Karar J; Cerniglia GJ; Lindsten T; Koumenis C; Maity A
Cancer Biol Ther; 2012 Sep; 13(11):1102-11. PubMed ID: 22895065
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory stimulation and hypoxia cooperatively activate HIF-1{alpha} in bronchial epithelial cells: involvement of PI3K and NF-{kappa}B.
Jiang H; Zhu YS; Xu H; Sun Y; Li QF
Am J Physiol Lung Cell Mol Physiol; 2010 May; 298(5):L660-9. PubMed ID: 20139176
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factors and sphingosine 1-phosphate signaling.
Cuvillier O; Ader I
Anticancer Agents Med Chem; 2011 Nov; 11(9):854-62. PubMed ID: 21707486
[TBL] [Abstract][Full Text] [Related]
20. GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathways.
Burrows N; Babur M; Resch J; Ridsdale S; Mejin M; Rowling EJ; Brabant G; Williams KJ
J Clin Endocrinol Metab; 2011 Dec; 96(12):E1934-43. PubMed ID: 21994956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]